More complete details surrounding the legal obligations of environmental remediation firms which utilize this combination are online at http://www.adventusgroup.com/about/press/2010-pr-4.shtml The purpose of these guidelines is to address considerable confusion or speculation in the industry concerning Adventus’ intellectual property (IP) rights in this respect. Adventus IP rights that pertain to these applications include No. 5,266,213 (30 November 1993), and No. 5,534,154 (9 July 1996).
Dr. Alan Seech, CEO of Adventus said, “Many firms with their own proprietary or patented bioremediation amendments, emplacement/injection methods, or specific project needs do respect intellectual property rights and have signed license agreements with Adventus. These firms have not found the license terms onerous, and have indeed benefited from our technical input on their projects, which is provided as part of the license agreement.
Adventus is committed to enforcing its IP rights. It is unfair to the licensees who do respect patent law, and thus obtain a license, to be at a cost disadvantage to those who abuse IP. Adventus remains willing to grant reasonable licenses under our U.S. Patents to suppliers of EVO or other carbon amendments who wish to add ZVI to their product, to consultants, to installation contractors, and to end users.'